Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07753824
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)Cancer Prevention Research Institute of TexasNot Yet RecruitingPhase 2
NCT07753824Not Yet Recruiting
Phase 2
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Pati...Cancer Prevention Researc...
NCT07753863
Use of a Silicone Sensor to Protect Fragile Neonatal Skin in Moderately Preterm Infants Needing Continuous Monitoring: the PRO-NEO-SKIN (Protect Neonatal Skin) Pilot StudyPaolo Manzoni Study GroupNot Yet RecruitingNot Applicable
NCT07753863Not Yet Recruiting
Not Applicable
Use of a Silicone Sensor to Protect Fragile Neonatal Skin in Moderately Preterm...Paolo Manzoni Study Group
NCT07756320
Precure Targeted Accrual and Rapid Growth in Enrollment Trial StudyMayo ClinicEnrolling By Invitation
NCT07756320Enrolling By Invitation
—
Precure Targeted Accrual and Rapid Growth in Enrollment Trial StudyMayo Clinic
NCT07753915
A Study on the Development and Application of a Cardiac Rehabilitation Nursing Intervention Protocol for Patients With First-Episode Acute Myocardial Infarction Following PCI, Based on a Socio-Ecological Theory ModelJinzhou Medical UniversityCompletedNot Applicable
NCT07753915Completed
Not Applicable
A Study on the Development and Application of a Cardiac Rehabilitation Nursing I...Jinzhou Medical Universit...
NCT07756372
A Multicenter, Superiority Randomized Controlled Trial of Three Interventions for Patients With a Progressive Collapsing Foot DeformityCanadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
NCT07756372Not Yet Recruiting
Not Applicable
A Multicenter, Superiority Randomized Controlled Trial of Three Interventions fo...Canadian Institutes of He...
NCT07754175
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a TrialKang Stem Biotech Co., Ltd.Recruiting
NCT07754175Recruiting
—
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and...Kang Stem Biotech Co., Lt...
NCT07753837
Web-based Acceptance and Commitment Therapy (ACT) Intervention for University StudentsNational University of Modern LanguagesCompletedNot Applicable
NCT07753837Completed
Not Applicable
Web-based Acceptance and Commitment Therapy (ACT) Intervention for University St...National University of Mo...
NCT07754292
Off-Label Treatment With Immune Checkpoint Inhibitor BlockadeMedical College of WisconsinNot Yet RecruitingPhase 2
NCT07754292Not Yet Recruiting
Phase 2
Off-Label Treatment With Immune Checkpoint Inhibitor BlockadeMedical College of Wiscon...
NCT07754071
Clinical Validation of an Artificial Intelligence System for De-termining Fetal Lie and Position in 3rd TrimesterCopenhagen Academy for Medical Education and SimulationRecruiting
NCT07754071Recruiting
—
Clinical Validation of an Artificial Intelligence System for De-termining Fetal...Copenhagen Academy for Me...
NCT07756099
Ba-Duan-Jin Training Versus NASM ApproachRashid Latif Medical CollegeCompletedNot Applicable
NCT07756099Completed
Not Applicable
Ba-Duan-Jin Training Versus NASM ApproachRashid Latif Medical Coll...
NCT07755748
Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response IncentivesCenters for Disease Control and PreventionNot Yet RecruitingNot Applicable
NCT07755748Not Yet Recruiting
Not Applicable
Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Inc...Centers for Disease Contr...
NCT07756268
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple SclerosisCSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07756268Not Yet Recruiting
Phase 1
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple SclerosisCSPC Baike (Shandong) Bio...
NCT07754279
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersMateria Medica HoldingCompletedPhase 1
NCT07754279Completed
Phase 1
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersMateria Medica Holding
NCT07755839
CanCOG®: Pilot Trial of Cognitive Rehabilitation for Cancer SurvivorsAveiro UniversityNot Yet RecruitingNot Applicable
NCT07755839Not Yet Recruiting
Not Applicable
CanCOG®: Pilot Trial of Cognitive Rehabilitation for Cancer SurvivorsAveiro University
NCT07754708
The Effect of Carpal Tunnel Syndrome Phenotyping on Response to TreatmentKutahya Health Sciences UniversityNot Yet RecruitingNot Applicable
NCT07754708Not Yet Recruiting
Not Applicable
The Effect of Carpal Tunnel Syndrome Phenotyping on Response to TreatmentKutahya Health Sciences U...
NCT07755150
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 DiabetesChendu DIAO Pharmaceutical Group CO., LTD.Not Yet RecruitingPhase 2
NCT07755150Not Yet Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects Wi...Chendu DIAO Pharmaceutica...
NCT07755956
Phase Ia Trial of HHK001 Compared With Enantone in Patients With EndometriosisZhuhai Huahaikang Pharmaceutical Technology Co., Ltd.Not Yet RecruitingPhase 1
NCT07755956Not Yet Recruiting
Phase 1
Phase Ia Trial of HHK001 Compared With Enantone in Patients With EndometriosisZhuhai Huahaikang Pharmac...
NCT07754786
A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic DermatitisInnovent Biologics (Suzhou) Co. Ltd.Not Yet RecruitingPhase 3
NCT07754786Not Yet Recruiting
Phase 3
A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Partic...Innovent Biologics (Suzho...
NCT07756346
A Study to Evaluate the Efficacy of Botulinum Toxin in Patients With Hidradenitis SuppurativaEmory UniversityNot Yet RecruitingPhase 2
NCT07756346Not Yet Recruiting
Phase 2
A Study to Evaluate the Efficacy of Botulinum Toxin in Patients With Hidradeniti...Emory University
Result Breakdown
Not yet recruiting13 (65%)
Completed4 (20%)
Recruiting2 (10%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Phase 24 (20%)
Not Specified3 (15%)
Phase 13 (15%)
Phase 31 (5%)